SRx Health Solutions Inc.

SRXH

SRXHSRx Health Solutions Inc. US flag

New York Stock Exchange American

0.12

USD

-0.01

- -

4.05MMarket Cap

Profitability (USD)

API Chat

	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -
Return on Assets (%)	- -	-213.47
Return on Capital (%)	- -	- -
Return on Invested Capital (%)	- -	- -
Gross Margin (%)	- -	23.35
EBITDA Margin (%)	- -	-174.09
Operating Margin (%)	- -	-174.56
Incremental Operating Margin (%)	- -	- -
Pretax Margin (%)	- -	-132.22
Profit Margin (%)	- -	-688.8
Net Income to Common Margin (%)	- -	-688.8
Effective Tax Rate (%)	- -	- -
Dvd Payout Ratio (%)	- -	- -
Sustainable Growth Rate (%)	- -	- -

Credit (USD)

API Chat

	2024 Y	2025 Y
Total Debt	45	4
ST Debt	39	- -
LT Debt	6	4
Total Debt/EBITDA	10.33	-0.39
Net Debt/EBITDA	8.69	-0.28
Total Debt/EBIT	- -	-0.39
Net Debt/EBIT	- -	-0.28
EBITDA to Interest Expense	- -	-18.11
EBITDA-CapEx/Interest Expense	- -	-21.42
EBIT to Interest Expense	- -	-18.16
Interest Expense	- -	1
Common Equity/Total Assets	-207.35	-272.52
Long-Term Debt/Equity (%)	- -	1,093.86
Long-Term Debt/Capital (%)	-25.58	-24.16
Long-Term Debt/Total Assets (%)	18.72	52.99
Total Debt/Equity (%)	-82.2	1,099.02
Total Debt/Capital (%)	-183.43	-24.28
Total Debt/Total Assets (%)	134.19	53.24
Net Debt to Equity	-69.14	772.24
Net Debt/Capital (%)	-153.63	-15.93
EBITDA	4	-11
EBITDA-CapEx	4	-13
Operating Income (Loss)	- -	-11

Liquidity (USD)

API Chat

	2024 Y	2025 Y
Cash Ratio	- -	0.37
Current Ratio	0.17	2.29
Quick Ratio	0.12	1.48
CFO/Avg Current Liab	- -	-0.19
Common Equity/Total Assets	-207.35	-272.52
Long-Term Debt/Equity (%)	- -	1,093.86
Long-Term Debt/Capital (%)	-25.58	-24.16
Long-Term Debt/Total Assets (%)	18.72	52.99
Total Debt/Equity (%)	-82.2	1,099.02
Total Debt/Capital (%)	-183.43	-24.28
Total Debt/Total Assets (%)	134.19	53.24
CFO/Total Liabilities	-1.66	-101.85
CFO/CapEx	- -	-3.92
Altman's Z-Score	-6.7	-6.28

Working Capital (USD)

API Chat

	2024 Y	2025 Y
Accounts Receivable Turnover	- -	0.99
Days Sales Outstanding	- -	369.25
Inventory Turnover	- -	1.84
Days Inventory Outstanding	- -	198.5
Accounts Payable Turnover	- -	0.18
Accounts Payable Turnover Days	- -	2,061.61
Cash Conversion Cycle	- -	-1,493.86
Inventory to Cash Days	- -	170.75
Inventories	3	2
Raw Materials	- -	1
Work In Process	- -	- -
Finished Goods	3	2
Other Inventory	- -	- -

Enterprise Value (USD)

API Chat

	2024 Y	2025 Y
Market Capitalization	- -	8
- Cash & Cash Equivalents	- -	1
+ Preferred Equity and Hybrid Capital	- -	- -
+ Minority/Non Controlling Interest	- -	- -
+ Total Debt	45	4
Enterprise Value	45	11
Total Capital	-25	-18
Total Debt/Capital (%)	-183.43	-24.28
Total Debt / EV	1	0.4
EV/Sales	- -	1.69
EV/EBITDA	10.3	- -
EV/EBIT	- -	- -
EV/Cash Flow to Firm	- -	- -
EV/Free Cash Flow to Firm	- -	- -
Diluted Market Cap	- -	8
Diluted Enterprise Value	45	11
EV per Share	3.16	0.44
TTM Sales	- -	7
TTM EBITDA	4	-11
TTM Operating Income	- -	-11
TTM Cash Flow to Firm	- -	-8
TTM Free Cash Flow to Firm	- -	-5

Multiples (USD)

API Chat

	2024 Y	2025 Y
Price/Free Cash Flow	- -	-1.3
EV/EBIT	- -	- -
Enterprise Value	45	11
Low Price	- -	0.26
EV/Sales	- -	1.69
EV/EBITDA	10.3	- -
Price/Earnings	- -	- -
Price/Earnings Average	- -	-0.33
Price/Earnings High	- -	-1.2
Price/Earnings Low	- -	-0.15
Price/Book Value	- -	-0.34
Price/Book Value Average	- -	-0.65
Price/Book Value High	- -	-2.35
Price/Book Value Low	- -	-0.29
Price/Tangible Book Value	- -	19.41
Price/Tangible Book Value Average	- -	36.74
Price/Tangible Book Value High	- -	132.23
Price/Tangible Book Value Low	- -	16.22
Price/Sales	- -	1.21
Price/Sales Average	- -	2.29
Price/Sales High	- -	8.24
Price/Sales Low	- -	1.01
Price/Cash Flow	- -	-0.97
Price/Cash Flow Average	- -	-1.84
Price/Cash Flow High	- -	-6.61
Price/Cash Flow Low	- -	-0.81
Price/Free Cash Flow Average	- -	-2.46
Price/Free Cash Flow High	- -	-8.87
Price/Free Cash Flow Low	- -	-1.09
EV/Sales Average	- -	2.77
EV/Sales High	- -	8.72
EV/Sales Low	- -	1.49
EV/EBITDA Average	10.3	-1.59
EV/EBITDA High	10.3	-5.01
EV/EBITDA Low	10.3	-0.86
EV/EBIT Average	- -	-1.59
EV/EBIT High	- -	-5
EV/EBIT Low	- -	-0.86
Last Price	- -	0.32
High Price	- -	2.16
Enterprise Value Average	45	18
Enterprise Value High	45	57
Enterprise Value Low	45	10

Profitability (USD)

API Chat

	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -
Return on Assets (%)	- -	-213.47
Return on Capital (%)	- -	- -
Return on Invested Capital (%)	- -	- -
Gross Margin (%)	- -	23.35
EBITDA Margin (%)	- -	-174.09
Operating Margin (%)	- -	-174.56
Incremental Operating Margin (%)	- -	- -
Pretax Margin (%)	- -	-132.22
Profit Margin (%)	- -	-688.8
Net Income to Common Margin (%)	- -	-688.8
Effective Tax Rate (%)	- -	- -
Dvd Payout Ratio (%)	- -	- -
Sustainable Growth Rate (%)	- -	- -

Credit (USD)

API Chat

	2024 Y	2025 Y
Total Debt	45	4
ST Debt	39	- -
LT Debt	6	4
Total Debt/EBITDA	10.33	-0.39
Net Debt/EBITDA	8.69	-0.28
Total Debt/EBIT	- -	-0.39
Net Debt/EBIT	- -	-0.28
EBITDA to Interest Expense	- -	-18.11
EBITDA-CapEx/Interest Expense	- -	-21.42
EBIT to Interest Expense	- -	-18.16
Interest Expense	- -	1
Common Equity/Total Assets	-207.35	-272.52
Long-Term Debt/Equity (%)	- -	1,093.86
Long-Term Debt/Capital (%)	-25.58	-24.16
Long-Term Debt/Total Assets (%)	18.72	52.99
Total Debt/Equity (%)	-82.2	1,099.02
Total Debt/Capital (%)	-183.43	-24.28
Total Debt/Total Assets (%)	134.19	53.24
Net Debt to Equity	-69.14	772.24
Net Debt/Capital (%)	-153.63	-15.93
EBITDA	4	-11
EBITDA-CapEx	4	-13
Operating Income (Loss)	- -	-11

Liquidity (USD)

API Chat

	2024 Y	2025 Y
Cash Ratio	- -	0.37
Current Ratio	0.17	2.29
Quick Ratio	0.12	1.48
CFO/Avg Current Liab	- -	-0.19
Common Equity/Total Assets	-207.35	-272.52
Long-Term Debt/Equity (%)	- -	1,093.86
Long-Term Debt/Capital (%)	-25.58	-24.16
Long-Term Debt/Total Assets (%)	18.72	52.99
Total Debt/Equity (%)	-82.2	1,099.02
Total Debt/Capital (%)	-183.43	-24.28
Total Debt/Total Assets (%)	134.19	53.24
CFO/Total Liabilities	-1.66	-101.85
CFO/CapEx	- -	-3.92
Altman's Z-Score	-6.7	-6.28

Working Capital (USD)

API Chat

	2024 Y	2025 Y
Accounts Receivable Turnover	- -	0.99
Days Sales Outstanding	- -	369.25
Inventory Turnover	- -	1.84
Days Inventory Outstanding	- -	198.5
Accounts Payable Turnover	- -	0.18
Accounts Payable Turnover Days	- -	2,061.61
Cash Conversion Cycle	- -	-1,493.86
Inventory to Cash Days	- -	170.75
Inventories	3	2
Raw Materials	- -	1
Work In Process	- -	- -
Finished Goods	3	2
Other Inventory	- -	- -

Enterprise Value (USD)

API Chat

	2024 Y	2025 Y
Market Capitalization	- -	8
- Cash & Cash Equivalents	- -	1
+ Preferred Equity and Hybrid Capital	- -	- -
+ Minority/Non Controlling Interest	- -	- -
+ Total Debt	45	4
Enterprise Value	45	11
Total Capital	-25	-18
Total Debt/Capital (%)	-183.43	-24.28
Total Debt / EV	1	0.4
EV/Sales	- -	1.69
EV/EBITDA	10.3	- -
EV/EBIT	- -	- -
EV/Cash Flow to Firm	- -	- -
EV/Free Cash Flow to Firm	- -	- -
Diluted Market Cap	- -	8
Diluted Enterprise Value	45	11
EV per Share	3.16	0.44
TTM Sales	- -	7
TTM EBITDA	4	-11
TTM Operating Income	- -	-11
TTM Cash Flow to Firm	- -	-8
TTM Free Cash Flow to Firm	- -	-5

Multiples (USD)

API Chat

	2024 Y	2025 Y
Price/Free Cash Flow	- -	-1.3
EV/EBIT	- -	- -
Enterprise Value	45	11
Low Price	- -	0.26
EV/Sales	- -	1.69
EV/EBITDA	10.3	- -
Price/Earnings	- -	- -
Price/Earnings Average	- -	-0.33
Price/Earnings High	- -	-1.2
Price/Earnings Low	- -	-0.15
Price/Book Value	- -	-0.34
Price/Book Value Average	- -	-0.65
Price/Book Value High	- -	-2.35
Price/Book Value Low	- -	-0.29
Price/Tangible Book Value	- -	19.41
Price/Tangible Book Value Average	- -	36.74
Price/Tangible Book Value High	- -	132.23
Price/Tangible Book Value Low	- -	16.22
Price/Sales	- -	1.21
Price/Sales Average	- -	2.29
Price/Sales High	- -	8.24
Price/Sales Low	- -	1.01
Price/Cash Flow	- -	-0.97
Price/Cash Flow Average	- -	-1.84
Price/Cash Flow High	- -	-6.61
Price/Cash Flow Low	- -	-0.81
Price/Free Cash Flow Average	- -	-2.46
Price/Free Cash Flow High	- -	-8.87
Price/Free Cash Flow Low	- -	-1.09
EV/Sales Average	- -	2.77
EV/Sales High	- -	8.72
EV/Sales Low	- -	1.49
EV/EBITDA Average	10.3	-1.59
EV/EBITDA High	10.3	-5.01
EV/EBITDA Low	10.3	-0.86
EV/EBIT Average	- -	-1.59
EV/EBIT High	- -	-5
EV/EBIT Low	- -	-0.86
Last Price	- -	0.32
High Price	- -	2.16
Enterprise Value Average	45	18
Enterprise Value High	45	57
Enterprise Value Low	45	10

	2024 Y	2025 Y
Shares Outstanding	14	25
Diluted Weighted Avg Shares	14	25
Basic Weighted Avg Shares	14	25
Revenue per Share	- -	0.26
EBITDA per Share	0.31	-0.46
Operating Income per Share	- -	-0.46
Basic EPS, GAAP	-3.01	-1.81
Basic EPS from Cont Ops	- -	-0.35
Diluted EPS, GAAP	-3.01	-1.81
Diluted EPS from Cont Ops	- -	-0.35
Dividend per Share	- -	- -
Cash Flow per Share	-0.1	-0.33
Free Cash Flow per Basic Share	-0.1	-0.41
Cash & Equivalents per Share	0.01	0.05
Book Value per Share	-4.9	-0.92
Tangible Book Value per Share	-4.34	0.02

SRx Health Solutions Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)